Stanley Weng
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Ferroptosis and cancer prognosis
-
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 9
- Prostate Cancer Diagnosis and Treatment 3
- Prostate Cancer Treatment and Research 2
- Surgery 5
- Bladder and Urothelial Cancer Treatments 4
- Co-authors
- Kyrollis Attalla (7 shared papers)A. Ari Hakimi (8 shared papers)Martin H. Voss (5 shared papers)Paul Russo (8 shared papers)Brian D. Robinson (2 shared papers)Neal Patel (1 shared paper)Samaneh Motanagh (2 shared papers)Andrew W. Silagy (7 shared papers)
- Journals
- Biotechnology and Bioengineering (2 papers)Cancer (1 paper)Clinical Cancer Research (1 paper)Urologic Clinics of North America (1 paper)Clinical Genitourinary Cancer (1 paper)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Stanley Weng
15 papers receiving 181 citations
Peers
Comparison fields: 5 of 44
- Pulmonary and Respiratory Medicine 140
- Cancer Research 27
- Rheumatology 24
- Radiology, Nuclear Medicine and Imaging 31
- Oncology 31
Countries citing papers authored by Stanley Weng
This map shows the geographic impact of Stanley Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley Weng more than expected).
Fields of papers citing papers by Stanley Weng
This network shows the impact of papers produced by Stanley Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley Weng. The network helps show where Stanley Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Stanley Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 56 | |
| 2 | 2020 | 33 | |
| 3 | 2020 | 27 | |
| 4 | 2012 | 18 | |
| 5 | 2021 | 14 | |
| 6 | 2021 | 11 | |
| 7 | 2014 | 6 | |
| 8 | 2021 | 5 | |
| 9 | 2023 | 3 | |
| 10 | 2021 | 3 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 1997 | 1 | |
| 14 | 2018 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2022 | 0 |
About Stanley Weng
Stanley Weng is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Cancer Research and Oncology, having authored 16 papers that have together received 182 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Cancer Genomics and Diagnostics (4 papers), Renal and related cancers (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Higher Education and Employability (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (140 citations), Cancer Research (27 citations), Rheumatology (24 citations), Radiology, Nuclear Medicine and Imaging (31 citations) and Oncology (31 citations). Stanley Weng has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Kyrollis Attalla, A. Ari Hakimi, Martin H. Voss, Paul Russo, Brian D. Robinson, Neal Patel, Samaneh Motanagh, Andrew W. Silagy, Khushabu Kasabwala and Jim C. Hu. Their work appears in journals such as Biotechnology and Bioengineering, Cancer, Clinical Cancer Research, Urologic Clinics of North America and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.